Melanoma

Antibody response to melanoma helper-peptide vaccine correlates with survival
Walter C Olson, Caroline M Reed, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P229; DOI: 10.1186/2051-1426-1-S1-P229
High dose interleukin-2 registry, PROCLAIM™; higher center-specific IL-2 dose density correlates with higher response rates
Michael K Wong, Gregory A Daniels, Howard L Kaufman, David F McDermott, Michael A Morse, Sandra Aung, James N Lowder

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P67; DOI: 10.1186/2051-1426-1-S1-P67
PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
Erica Huelsmann, Joseph Broucek, Andrew Lacek, Eugene Lusciks, Johnson Saba, Arman Nabatiyan, Andrew Zloza

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P156; DOI: 10.1186/2051-1426-1-S1-P156
Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma
Rachel L Sabado, Anna Pavlick, Sacha Gnjatic, Crystal Cruz, Isabelita Vengco, Farah Hasan, Farbod Darvishian, Luis Chiriboga, Rose Marie Holman, Juliet Escalon, Caroline Muren, Crystal Escano, Ethel Yepes, Dunbar Sharpe, Sylvia Adams, Patrick Ott, Achim Jungbluth, Linda Pan, Ralph Venhaus, Nina Bhardwaj

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P272; DOI: 10.1186/2051-1426-1-S1-P272
Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identification
Drew Hotson, Ryan Alvarado, Andrew Conroy, Santosh Putta, Ester Simeone, Assunta Esposito, Mariaelena Capone, Gabriele Madonna, Antonio M Grimaldi, David Rosen, Spencer Liang, Alessandra Cesano, Paolo A Ascierto, Rachael Hawtin

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P257; DOI: 10.1186/2051-1426-1-S1-P257
Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
Jie Qing Chen, Caitlin Creasy, Carlos Antonio Torres Cabala, Suhendan Ekmekcioglu, Sourindra N Maiti, Jason Roszik, Cara Haymaker, Chantale Bernatchez, Patrick Hwu, Laszlo Radvanyi

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P48; DOI: 10.1186/2051-1426-1-S1-P48
Stereotactic body radiation therapy and CTLA-4 blockade as a novel therapy for advanced melanoma
Christina Twyman, Andrew Rech, Ramesh Rengan, Robert Vonderheide, Andy Minn

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P118; DOI: 10.1186/2051-1426-1-S1-P118
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Ileana S Mauldin, Ena Wang, Donna H Deacon, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) O17; DOI: 10.1186/2051-1426-1-S1-O17
The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg
Antonio M Grimaldi, Ester Simeone, Diana Giannarelli, Marco Palla, Paolo Muto, Sara Falivene, Fabio Sandomenico, Antonella Petrillo, Marcello Curvietto, Assunta Esposito, Miriam Paone, Corrado Caracò, Gennaro Ciliberto, Nicola Mozzillo, Paolo A Ascierto

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) O23; DOI: 10.1186/2051-1426-1-S1-O23
Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival
Joseph R Broucek, Tasha Hughes, Erica J Huelsmann, Joseph L Poshepny, Carl E Ruby, Andrew Zloza, Howard L Kaufman

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P70; DOI: 10.1186/2051-1426-1-S1-P70

Main menu

Melanoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma

Pages